Partner
In the News
K&S Counsels MiMedx in FDA Classification Dispute
September 22, 2026
| Law360K&S counsels MiMedx in a dispute with the FDA before a Georgia federal court.
FDA Must Revisit MiMedx Wound Care Powder Classification (Law360)
Featured Lawyers
Paul Alessio Mezzina
Partner
Business Litigation
Jeffrey K. Shapiro
Partner
Government Matters & Regulation
Madison H. Kitchens
Partner
Product Liability & Mass Torts
Matthew Washnock
Associate
Business Litigation
Explore King & Spalding
Capabilities
FDA & Life Sciences
Capabilities
Appellate, Constitutional & Administrative Law